Qube Research & Technologies (QRT)
ALLO icon

Qube Research & Technologies (QRT)’s Allogene Therapeutics ALLO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-585,706
Closed -$1.88M – 4434
2023
Q4 		$1.88M Buy
+585,706
New +$1.66M ﹤0.01% 1562
2023
Q2 		– Sell
-135,244
Closed -$668K – 2359
2023
Q1 		$668K Sell
135,244
-51,833
-28% -$332K ﹤0.01% 1451
2022
Q4 		$1.18M Buy
187,077
+70,020
+60% +$648K 0.01% 1150
2022
Q3 		$1.26M Buy
+117,057
New +$1.59M 0.01% 1108

Other funds holding ALLO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ALLO Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of Allogene Therapeutics (ALLO) in Q1 2024, closing a stake of 585,706 shares — an estimated $1.88M sold.

Qube Research & Technologies (QRT) first reported a position in ALLO in Q3 2022 and held it in 4 quarters. The position peaked at $1.88M in Q4 2023. 161 funds tracked by Wall St. Rank hold ALLO as of Q1 2024.

  • Qube Research & Technologies (QRT) reported no remaining Allogene Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 585,706 Allogene Therapeutics shares in Q1 2024, an estimated $1.88M.
  • Qube Research & Technologies (QRT) first reported a position in Allogene Therapeutics in Q3 2022 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Allogene Therapeutics position peaked at $1.88M in Q4 2023.
  • 161 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.